Authors

• Katherine R. Marks (ORCID: https://orcid.org/0000-0001-5936-7497)
• Emmanuel Oga
• Kitty H. Gelberg (ORCID: https://orcid.org/0000-0002-3734-3280)
• SHARON L. WALSH (ORCID: https://orcid.org/0000-0002-9722-5681)
• Denise C. Babineau (ORCID: https://orcid.org/0000-0002-9776-9080)
• Jennifer Villani (ORCID: https://orcid.org/0000-0003-2337-2504)
• Rachel Vickers‐Smith (ORCID: https://orcid.org/0000-0002-7224-8916)
• Louisa Gilbert (ORCID: https://orcid.org/0000-0003-2715-8310)
• Janet E. Childerhose (ORCID: https://orcid.org/0000-0003-0985-1306)
• Carter Roeber (ORCID: https://orcid.org/0000-0001-6967-6453)
• Patricia LeBaron
• James L. David (ORCID: https://orcid.org/0009-0009-6738-8031)
• Laura C. Fanucchi (ORCID: https://orcid.org/0000-0003-0582-2399)
• Megan E. Hall (ORCID: https://orcid.org/0000-0001-8163-5988)
• Barry Eggleston
• Megan E. Dzurec
• Redonna K. Chandler
• Mary Russo (ORCID: https://orcid.org/0000-0001-5683-2250)
• Nabila El–Bassel
• K. Lancaster

Institutions

• Atrium Health Wake Forest Baptist (US)
• National Institute on Drug Abuse (US)
• Substance Abuse and Mental Health Services Administration (US)
• Kentucky Department of Education (US)
• University of Kentucky (US)
• RTI International (US)
• University Press of Kentucky (US)
• Kentucky Department for Public Health (US)
• Department of Behavioral Health and Intellectual Disability Services (US)
• The Ohio State University (US)
• Columbia University (US)

Publication Details

Journal

International Journal of Drug Policy

Published

2025-06-09

DOI

https://doi.org/10.1016/j.drugpo.2025.104867

Citations

5

Primary Topic

Opioid Use Disorder Treatment

Type

article

Field-Weighted Citation Impact

9.39

Funders

• National Institutes of Health
• Substance Abuse and Mental Health Services Administration